# FDA Inspection 1146853 - REATA PHARMACEUTICALS - July 13, 2021

Source: https://www.keypedia.com/records/fda_inspections/reata-pharmaceuticals/1b59d3b8-fc60-4320-bf24-154aebef63c7
Source feed: FDA_Inspections

> FDA Inspection 1146853 for REATA PHARMACEUTICALS on July 13, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1146853
- Company Name: REATA PHARMACEUTICALS
- Inspection Date: 2021-07-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/reata-pharmaceuticals/90089a9c-06f6-4450-aefa-9e6489b27330

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
